It all begins with our simple design to spread the word…

our sole objective is to raise awareness of rare cancers with our logo and merchandise.

we reinvest profits and give to charities who can then provide treatment and research for future patients.

OUR PRODUCTS provide funds for the treatment and care of future rare cancer patients.

Make a donation.

Order a t shirt and make a donation today so we can start reinvesting in the research and treatment of rare cancers to support future patients.

Our partners who we reinvest profits towards

our CHARITIES

what is soulheart?

‘Soulheart is a very special project. Alex is selflessly taking his own experience of sarcoma and turning it into something positive and uplifting.

Proceeds from the sale of Soulheart products will benefit Sarcoma UK and future sarcoma patients – helping to increase our knowledge and understanding of the disease.

We are really grateful to Alex for sharing his and Jackie’s story and for donating some of the proceeds from these inspiring products.’

Richard Davidson, CEO Sarcoma UK

‘The H&T Clients Charitable trust cancer fund pays for specialist cancer treatment for patients which are recommended by a Patient's Doctor but not available to the patient on the NHS. To date we have raised in excess of £1.8m and helped numerous patients. Each patient we have funded has also, together with their family and friends, raised funds for the next patient. The majority of our funding has provided immunotherapy treatment.

We are pleased to be associated with Soulheart and Alex's commitment to this project. Jackie was supported by our charity with her own treatment and we will continue to support Alex where possible.

We wish the Soulheart project much success.’

NEVILLE NEWMAN, HARRIS & TROTTER CHARITABLE TRUST

H&T operate a charitable trust, H&T Clients Charitable Trust (charity number 1104345) which has two strands.

The first is to pay for specialist cancer treatment for patients which are recommended by a Patients Doctor but not available to the patient on the NHS. To date we have raised in excess of £1.8m and helped numerous patients. Each patient we have funded has also, together with their family and friends, raised funds for the next patient. The majority of our funding has provided immunotherapy treatment.

The second strand arises from the Firm’s decision to add £8 to each of our invoices and upon payment by a Client to match this funding ourselves. We have supported many charities this way often proposed by Clients, members of staff and Partners recommending causes close to their heart. We raise currently in excess of £150,000 per annum in this way.